FLAME 30
239 Reports in Biotechnology
Single-Cell Genomics and Proteomics: Emerging Technologies and Ma...
The global single-cell analysis market was valued at $541.2 million in 2014. This market is projected to grow from $626.2 million in 2015 to $1.6 billion in 2020, at a compound annual growth rate (CAGR) of 20.7% from 2015 to 2020.
Microbial Products: Technologies, Applications and Global Markets
The global market for microbes and microbial products was valued at $143.5 billion in 2014. The 2015 market is projected to approach $154.7 billion, and the 2020 market, nearly $306 billion, with a compound annual growth rate (CAGR) of 14.6% from 2015 to 2020.
Cell Expansion Technologies and Global Markets
The global cell expansion market generated revenue of roughly $8.5 billion in 2014, and is expected to reach revenues of $9.7 billion in 2015 and $22.0 billion by 2020, with a compound annual growth rate (CAGR) of 17.8% from 2015 to 2020.
Botanical and Plant-Derived Drugs: Global Markets
The global market for botanical and plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $25.6 billion in 2015 and nearly $35.4 billion in 2020, with a compound annual growth rate (CAGR) of 6.6% from 2015 to 2020.
The U.S. Market for Biodefense-Related Rapid Pathogen Identificat...
The projected U.S. market for biodefense-related rapid pathogen detection devices is valued at $214.2 million in 2015. The total market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2016 through 2021 and reach $248 million by 2016 and $364 million by 2021.
Next Generation Sequencing: Emerging Clinical Applications and Gl...
The global clinical next-generation sequencing (NGS) market was valued at $886.1 million in 2014. This market is expected to grow at a compound annual growth rate (CAGR) of 31.3%, from $997.1 million in 2015 to nearly $3.9 billion by 2020.
Molecular Diagnostics: Technologies and Global Markets
The global molecular diagnostics market was valued at almost $21.7 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2015 through 2020 to reach nearly $25.2 billion by 2015 and $45.2 billion by 2020.
Single-Use Technologies for Biopharmaceuticals: Global Markets
The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for cell culture products will grow from nearly $3.2 billion in 2014 to nearly $4.1 billion by 2019 at a compound annual growth rate (CAGR) of 5.1% between 2014 and 2019.
Proteomics: Technologies and Global Markets
The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.
Drug Discovery Technologies
The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.
Global Markets for Research Antibodies
The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019.
Biosimilars: Global Markets
The global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014. The market is expected to reach nearly $4.0 billion by 2019, with a compound annual growth rate (CAGR) of 15% from 2014 through 2019.
2014 Biotechnology Research Review
This BCC Research review report provides highlights from biotechnology market research reports published in 2014. It covers topics like bioengineered protein drugs, synthetic biology, cancer profiling, microbiology technology, induced pluripotent stem cells, and PCR technology.
Biological Therapies for Cancer: Technologies and Global Markets
The global market for biologic cancer treatment totaled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019.
Antibody Drugs: Technologies and Global Markets
The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting in totals nearly $68.9 billion in 2014 and $122.6 billion globally in 2019.
3D Cell Cultures: Technologies and Global Markets
The three dimensional cell culture market was $438.1 million in 2013. This market is expected to grow to $586.1 million in 2014 and about $2.2 billion in 2019, with a compound annual growth rate (CAGR) of 30.1%.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global biologics market totaled $200.6 billion in 2013 and is expected to grow to nearly $234 billion in 2014. The total market is expected to grow to $386.7 billion by the end of 2019 at compound annual growth rate (CAGR) of 10.6%.
Renal Biomarkers: Technologies and Global Markets
The in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014. The market is expected to reach $1.1 billion by 2019, a compound annual growth rate (CAGR) of 7% from 2014 to 2019.
Agricultural Biotechnology: Emerging Technologies and Global Mark...
The global market for agricultural biotechnology reached $26.4 billion in 2013 and $27.8 billion in 2014. This indication is expected to reach $46.8 billion in 2019, registering a compound annual growth rate (CAGR) of 11.0% over the next five years.
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Ma...
The global market for nucleic acid aptamers reached $340.5 million in 2014. This market should grow to about $610.3 million in 2015 and about $5.4 billion in 2019, with a compound annual growth rate (CAGR) of 73.5% from 2014 to 2019.
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and...
The global single nucleotide polymorphism (SNP) genotyping market was valued at $3.5 billion in 2013. This market is expected to reach $4.3 billion in 2014 and $11.5 billion in 2019, a compound annual growth rate (CAGR) of 21.9% from 2014 to 2019.
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Mar...
The global market for microRNA (miRNA) research tools, services, diagnostics and drug discovery was valued at $478.8 million in 2013. This market is expected to reach $572 million in 2014 and $1 billion in 2019, at a compound annual growth rate (CAGR) of 12.6% for the period of 2014 to 2019.
Next Generation Cancer Diagnostics: Technologies and Global Marke...
BCC Research estimates the global market for next generation cancer diagnostic as $1.6 billion in 2013. This indication is expected to reach $1.8 billion in 2014 and $10 billion in 2019, registering a compound annual growth (CAGR) of 42.6% over the next five years.
Nanoparticles in Biotechnology, Drug Development and Drug Deliver...
The global market for nanoparticles in biotechnology and pharmaceuticals reached nearly $25.0 billion in 2013. This market is expected to reach $29.6 billion in 2014 and $79.8 billion in 2019, with a compound annual growth rate (CAGR) of 22.0% for the period of 2014 to 2019.
Choose your License
10 Upcoming Reports in Biotechnology
Global Longevity and Anti-senescence Therapy market
Report Includes
- An overview of the global longevity and anti-senescence therapy market
- Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Detailed description of different therapies such as senolytic drug therapy, gene therapy, and immunotherapy and discussion on how these slow down or reverse aging process
- Coverage of drugs, devices and technologies and information about the various compounds used for the development of anti-ageing therapeutics
- A look at the clinical trials and expected launch of anti-senescence products
- Detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market
Global Microbiome Sequencing Market
Report Includes
- An overview of the global market and technologies for genome sequencing
- Analyses of global market trends, with data from 2017, 2018 and projections of CAGRs through 2023
- Analysis of the present and future opportunities and key factors influencing the in-microbiome sequencing market
- Discussion on impact of genome sequencing on pharmaceutical, biotechnology and healthcare sectors
- Information on automated instruments and discussion on how it facilitates speedy sequencing procedures
- Insights into government initiatives and funding for the development of effective drugs for the treatment and prevention from chronic diseases
- Company profiles of the major players of the market
